Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2000
05/24/2000EP1001933A1 Caspases and apoptosis
05/24/2000EP1001930A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
05/24/2000EP1001774A1 Use of phospholamban inhibitors to increasing coronary flow
05/24/2000CN1254337A N-hydroxy 4-sulfonyl butyramide compounds
05/24/2000CN1254335A Nicotinamide derivatives
05/24/2000CN1254333A Immunotherapeutic imides/amides
05/24/2000CN1253948A Substituted tricyclic compound
05/24/2000CN1052723C Bicyclic aromatic compounds as therapeutic agents, its preparing method and drug composition containing said compound
05/23/2000US6066748 Process of extracting TAXOL® from taxus cuspidata
05/23/2000US6066740 From thiourea intermediate; for treatment of respiratory disorders, ocular disorders, gastrointestinal disorders, nasal decongestion, hypertension, migraine, disorders associated with sympathetic nervous system activity, and substance abuse
05/23/2000US6066730 Boronic ester and acid compounds, synthesis and uses
05/23/2000US6066655 For the treatment of central nervous system disorders, in particular as cerebral therapeutics
05/23/2000US6066651 Antithrombotic agents by virtue of their ability to prevent platelet aggregation
05/23/2000US6066650 Inhibitors of microsomal triglyceride transfer protein and method
05/23/2000US6066648 Integrin receptor antagonists
05/23/2000US6066642 For selectively blocking the a3 adenosine receptor of a mammal
05/23/2000US6066638 Fungicidal pyrimidinones
05/23/2000US6066637 Indolyl derivatives as serotonergic agents
05/23/2000US6066636 Muscarinic antagonists
05/23/2000US6066632 Heterocyclic compounds
05/23/2000US6066597 For crops
05/18/2000WO2000027845A1 Spiro-indolines as y5 receptor antagonists
05/18/2000WO2000027842A1 Compounds
05/18/2000WO2000027841A1 Method of preparing sulfide derivatives
05/18/2000WO2000027825A1 Hiv replication inhibiting pyrimidines
05/18/2000WO2000027823A1 Gastrin and cholecystokinin receptor ligands
05/18/2000WO2000027822A2 Tricyclic pyrazole derivatives
05/18/2000WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/18/2000WO2000027819A2 Antrhranilic acid amides and the use thereof as medicaments
05/18/2000WO2000027812A1 Phenyl-substituted cyclic enaminones
05/18/2000WO2000027811A1 Neurotrophic diamide and carbamate agents
05/18/2000WO2000027792A1 Novel compounds and medicinal use thereof
05/18/2000WO2000027394A1 Activators of soluble guanylate cyclase
05/18/2000WO2000027366A1 Pharmaceutical formulation comprising omeprazole
05/18/2000WO2000010553A3 Carbamate and urea compositions and neurotrophic uses
05/18/2000WO2000009479A3 Heterocyclic thioesters or ketones for vision and memory disorders
05/18/2000WO2000009130A3 New pharmaceutical uses for nos inhibitors
05/18/2000WO2000009098A3 Method for treating ocular neovascular diseases
05/18/2000WO2000008202A3 3-methylidenyl-2-indolinone modulators of protein kinase
05/18/2000WO2000004892A3 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/18/2000DE19851986A1 Phenyl-substituierte zyklische Enaminone Phenyl-substituted cyclic enaminones
05/18/2000CA2350714A1 Spiro-indolines as y5 receptor antagonists
05/18/2000CA2350429A1 Neurotrophic diamide and carbamate agents
05/18/2000CA2350305A1 Phenyl-substituted cyclic enaminones
05/18/2000CA2350235A1 Tricyclic pyrazole derivatives
05/18/2000CA2350208A1 Antrhranilic acid amides and the use thereof as medicaments
05/18/2000CA2348763A1 Novel compounds and medicinal use thereof
05/18/2000CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/18/2000CA2346108A1 Gastrin and cholecystokinin receptor ligands
05/17/2000EP1000999A1 Compounds for organic el devices and organic el devices
05/17/2000EP1000943A1 Sulfoxide compounds and acetone complexes, and a process for producing the same
05/17/2000EP1000930A2 Tachykinin antagonists
05/17/2000EP1000621A2 Use of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz (CD) indoles for treating motion sickness and vomiting
05/17/2000EP1000058A1 2- pyrazolyl and triazolyl-3'-oxymethylene]-phenyl-isoxazolones, triazolones and tetrazolones as pesticides and fungicides
05/17/2000EP1000057A1 Pyridyl- and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclase
05/17/2000EP1000056A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
05/17/2000EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
05/17/2000EP1000046A1 Piperazine derivatives active on the lower urinary tract
05/17/2000EP1000040A1 Il-5 inhibiting 6-azauracil derivatives
05/17/2000EP1000039A1 Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
05/17/2000EP1000036A1 Hydantoin derivatives having an inhibitory activity for farnesyl transferase
05/17/2000EP1000035A1 Substituted 6-phenylphenanthridines
05/17/2000EP1000033A1 Heterocyclic derivatives which inhibit factor xa
05/17/2000EP1000028A1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
05/17/2000EP1000025A1 Substituted naphthopyrans
05/17/2000EP0999856A2 Radiopharmaceuticals for imaging infection and inflammation
05/17/2000EP0999842A1 Novel substituted imidazole compounds
05/17/2000EP0770066B1 Serotonin 5-ht 1a and dopamin d2 receptor ligands
05/17/2000CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction
05/17/2000CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds
05/17/2000CN1253558A Substituted imidazoles useful in treatment of inflammatory diseases
05/17/2000CN1253557A Vitamin D3 analogs with bis C-20 side chains
05/17/2000CN1253553A Substituted phenyl derivatives, their preparation and use
05/17/2000CN1253548A HIV protease inhibitors
05/17/2000CN1253547A 1,4-substituted cyclic amine derivatives
05/17/2000CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases
05/17/2000CN1253528A Optical recording media
05/17/2000CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/17/2000CN1052478C Process for preparation of 1,4-disubstituted-5(4H)-tetrazolinones
05/17/2000CN1052476C N-cyanoaryl-nitrogen heterocycles and its producing process, use and intermediate
05/16/2000US6063956 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides
05/16/2000US6063934 Neuropeptide y antagonists
05/16/2000US6063926 Having greater bioactivity
05/16/2000US6063911 Methods and compositions for treatment of cell proliferative disorders
05/16/2000US6063804 Pyrrole compounds
05/16/2000US6063798 Substituted N-methylenethioureas as pesticides
05/16/2000US6063796 Heterocyclic compounds of piperidine
05/16/2000US6063791 N-benzenesulfonyl-L-proline derivatives, method for preparing and therapeutic use
05/16/2000US6063789 Antiinflammatory agents
05/16/2000US6063785 Isomers of drugs for racemic mixtures
05/16/2000US6063734 Agricultural chemicals, agents for preventing attachment of aquatic organisms
05/16/2000CA2126752C Benzopyran and related ltb4 antagonists
05/16/2000CA1340991C A-unsaturated amines, their production and use
05/11/2000WO2000026211A1 Thrombin inhibitors
05/11/2000WO2000026210A1 Thrombin inhibitors
05/11/2000WO2000026209A1 Anti-inflammatory 4-phenyl-5-pyrimidinyl-imidazoles
05/11/2000WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/11/2000WO2000026201A1 Benzoylpyridazines
05/11/2000WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use